Latest news for C&C Group (OTC:CCGPY) Stock

C&C Group PLC manufactures cider and other alcoholic and nonalcoholic beverages, including beer, wine, soft drinks, and bottled water. The company's brands include Bulmers, Tennet's, Magners, Heverlee, Woodchuck, Hornsby's, Gaymers, Blackthorn, Tipperary, Finches, and Others. C&C also has distribution rights for numerous brands owned by other companies. Its geographical segments are Ireland, Great Britain, and International, of which the majority of its revenue comes from Great Britain.

C&C Group PLC

Providing a diverse range of perspectives from bullish to bearish, 9 analysts have published ratings on Molson Coors Beverage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) in the last three months.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $61.33, a high estimate of $74.00, and a low estimate of $48.00. This current average reflects an increase of 14.49% from the previous average price target of $53.57. 
<img src="https://www.benzinga.com/files/images/story/2025/1738756812_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The standing of Molson Coors Beverage among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Filippo Falorni</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$57.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$58.00</td>
<td>$59.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$48.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$58.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Bryan Spillane</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$70.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Gerald Pascarelli</td>
<td>Needham</td>
<td>Announces</td>
<td>Buy</td>
<td>$72.00</td>
<td>-</td>
</tr>
<tr>
<td>Kevin Grundy</td>
<td>Exane BNP Paribas</td>
<td>Announces</td>
<td>Neutral</td>
<td>$64.00</td>
<td>-</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$51.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>Chris Carey</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$74.00</td>
<td>$52.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Molson Coors Beverage. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Molson Coors Beverage compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Molson Coors Beverage's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Molson Coors Beverage's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/TAP/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Molson Coors Beverage analyst ratings.</a>
<h2>Discovering Molson Coors Beverage: A Closer Look</h2>
Molson Coors owns well-known beer brands including Miller, Coors, Blue Moon, and Carling and ranks as the second-largest beer maker in both value and volume terms in the us, Canada, and the United Kingdom. Through licensing agreements, the firm also brews and distributes beer and hard seltzer under partner brands from Heineken, Anheuser-Busch InBev, Asahi, and Coca-Cola. The brewer uses independent distributors in the us, given the three-tier distribution requirements, while using a combination of distributors and an in-house sales team in Canada and Europe. North America remains its largest market, contributing over 80% of total revenue.
<h3>Breaking Down Molson Coors Beverage's Financial Performance</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Challenges: Molson Coors Beverage's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately -7.75%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Molson Coors Beverage's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 6.57%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Molson Coors Beverage's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 1.51%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Molson Coors Beverage's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.74%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a high debt-to-equity ratio of 0.47, Molson Coors Beverage faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: What Are They?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Deep Dive Into Molson Coors Beverage Stock: Analyst Perspectives (9 Ratings)

Vestas Wind Systems (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VWDRY#OTC">VWDRY</a>) announced its Q4 earnings on Wednesday, February 5, 2025 at 03:00 AM.
Here's a breakdown of the earnings report.
<h3>Earnings</h3>
Vestas Wind Systems beat estimated earnings by 31.0%, reporting an EPS of $0.21 versus an estimate of $0.16.
Revenue was up $1.42 billion from the same period last year.
<h3>Overview of Past Earnings</h3>
The company missed on EPS by $0.03 in the previous quarter, leading to a 14.000000000000002% drop share price change the next day.

To track all earnings releases for Vestas Wind Systems <a href="https://www.benzinga.com/quote/VWDRY/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

VWDRY

Recap: Vestas Wind Systems Q4 Earnings

News

Guidance

UBER

Uber Sees Adj. EBITDA $1.79B-$1.89B

The Company initiated fiscal 2025 second quarter guidance:
<ul>
<li>Organic sales growth of mid-single digits</li>
<li>Adjusted segment EBITA margin of ~16.5%</li>
<li>Adjusted EPS before special items of ~$0.77 to $0.79</li>
</ul>
The Company raised fiscal 2025 full year guidance:
<ul>
<li>Organic sales growth of mid-single digits (unchanged)</li>
<li>Adjusted segment EBITA margin improvement of more than 80 basis points, year-over-year (previously more than 50 bps)</li>
<li>Adjusted EPS before special items of ~$3.50 to $3.60 (previously ~$3.40 to $3.50)</li>
</ul>

Johnson Controls Intl Sees Q2 Adj EPS $0.77-$0.79 vs $0.73 Est

Uber Sees Q1 2025 Gross Bookings Growth 17%-21%

Keybanc analyst John Vinh maintains Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) with a Overweight and lowers the price target from $150 to $140.

Price Target

Keybanc Maintains Overweight on Advanced Micro Devices, Lowers Price Target to $140

Johnson Controls Building Solutions Backlog $13.20B +11% YoY

Vestas Wind Systems (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VWDRY#OTC">VWDRY</a>) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.16 by 31.25 percent. This is a 600 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $6.55 billion which beat the analyst consensus estimate of $5.75 billion by 13.91 percent. This is a 27.63 percent increase over sales of $5.13 billion the same period last year.

Earnings Beats

Vestas Wind Systems Q4 EPS $0.21 Beats $0.16 Estimate, Sales $6.55B Beat $5.75B Estimate

Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) reported quarterly sales of $12.00 billion which beat the analyst consensus estimate of $11.77 billion by 1.98 percent. This is a 20.77 percent increase over sales of $9.94 billion the same period last year.

Uber Technologies Q4 Sales $12.00B Beat $11.77B Estimate

He succeeds George R. Oliver following a thorough succession planning process.&nbsp;

Management

Johnson Controls Appoints Joakim Weidemanis As CEO Effective March 12, 2025;

As of Feb. 5, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the<a href="https://www.benzinga.com/topic/rsi"> RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Orthofix Medical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFIX#NASDAQ">OFIX</a>)</h3>
<ul>
<li>Orthofix Medical announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday, Feb. 25, 2025 before the opening bell. The company has a <a href="https://www.benzinga.com/quote/OFIX">52-week high of $20.73</a>.</li>
<li>RSI Value: 77.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>OFIX Price Action: Shares of Orthofix Medical gained 3.1% to close at $18.76 on Tuesday.</li>
</ul>
<h3 class="wp-block-heading">Globus Medical Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>)</h3>
<ul>
<li>On Feb. 3, Interactive Brokers reported a year-over-year increase in daily average revenue trades for January. The company's stock gained around 10% over the past month and <a href="https://www.benzinga.com/quote/GMED">has a 52-week high</a> of $94.93.</li>
<li>RSI Value: 74</li>
<li>GMED Price Action: Shares of Globus Medical fell 0.4% to close at $92.18 on Tuesday.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43460681/jim-cramer-says-no-to-bigbear-ai-recommends-buying-this-tech-stock">Jim Cramer Says No To BigBear.ai, Recommends Buying This Tech Stock</a></li>
</ul>

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

GMED

OFIX

Top 2 Health Care Stocks That May Crash In February

Johnson Controls Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>) reported quarterly earnings of $0.64 per share which beat the analyst consensus estimate of $0.59 by 8.47 percent. This is a 39.13 percent increase over earnings of $0.46 per share from the same period last year. The company reported quarterly sales of $5.43 billion which beat the analyst consensus estimate of $5.29 billion by 2.50 percent. This is a 4.17 percent increase over sales of $5.21 billion the same period last year.

Johnson Controls Intl Q1 2025 Adj EPS $0.64 Beats $0.59 Estimate, Sales $5.43B Beat $5.29B Estimate

Timken Says It Is Implementing Cost Reduction Actions That Are Expected To Generate Gross Savings Of $75M In 2025

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Baird analyst Peter Arment upgraded Mercury Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRCY#NASDAQ">MRCY</a>) from Neutral to Outperform and raised the price target from $37 to $58. Mercury shares closed at $42.09 on Tuesday. <a href="https://www.benzinga.com/quote/MRCY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Brian Tanquilut upgraded the rating for Cardinal Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) from Hold to Buy and raised the price target from $140 to $150. Cardinal Health shares closed at $125.17 on Tuesday. <a href="https://www.benzinga.com/quote/CAH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Kenneth Worthington upgraded Janus Henderson Group plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JHG#NYSE">JHG</a>) from Neutral to Overweight and boosted the price target from $44 to $53. Janus Henderson shares closed at $44.02 on Tuesday. <a href="https://www.benzinga.com/quote/JHG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Christopher Danely upgraded the rating for NXP Semiconductors N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) from Sell to Neutral and raised the price target from $200 to $210. NXP Semiconductors shares closed at $202.40 on Tuesday. <a href="https://www.benzinga.com/quote/NXPI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Benchmark analyst Cody Acree upgraded Silicon Laboratories Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>) from Hold to Buy and maintained the price target of $160. Silicon Laboratories shares closed at $136.60 on Tuesday. <a href="https://www.benzinga.com/quote/SLAB/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying NXPI stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="612" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05065433/image-40-1024x612.png" alt="" class="wp-image-766905" style="width:585px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05065433/image-40-1024x612.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05065433/image-40-300x179.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05065433/image-40-768x459.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05065433/image-40.png 1082w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43460681/jim-cramer-says-no-to-bigbear-ai-recommends-buying-this-tech-stock">Jim Cramer Says No To BigBear.ai, Recommends Buying This Tech Stock</a></li>
</ul>

Upgrades

Janus Henderson Group plc Ordinary Shares

MRCY

NXPI

SLAB

This NXP Semiconductors Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday

Harley-Davidson shares are trading lower following a Q4 earnings miss.

Timken Sees 2025 Adjusted EPS Of $5.30 - $5.80, Est $6.32; Revenue To Decline 4% To 1% In Total YoY, Including Unfavorable Foreign Currency Translation

Harley-Davidson Sees Full-Year HDMC Revenue Flat To Down 5%, Operating Income Margin 7.0%-8.0%, Sees Full-Year Diluted EPS Flat To Down 5%

Harley-Davidson Q4 HDMC Revenue $420.489M

Timken (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TKR#NYSE">TKR</a>) reported quarterly earnings of $1.16 per share which beat the analyst consensus estimate of $0.99 by 17.17 percent. This is a 15.33 percent decrease over earnings of $1.37 per share from the same period last year. The company reported quarterly sales of $1.07 billion which met the analyst consensus estimate. This is a 1.65 percent decrease over sales of $1.09 billion the same period last year.

Timken Q4 2024 Adj EPS $1.16 Beats $0.99 Estimate, Sales $1.073B Beats $1.067B Estimate

On Tuesday, February 4, U.S. markets closed higher, driven by energy sector gains, as optimism grew over a potential U.S.-China trade breakthrough. Trump delayed Mexico-Canada tariffs but imposed new levies on China, prompting retaliation. Strong corporate earnings lifted sentiment, with <a target="_blank" href="https://www.benzinga.com/news/earnings/earnings-beats/25/02/43468342/palantir-rockets-on-strong-q4-2024-was-only-a-dress-rehearsal-for-ai-growth-says-analyst" rel="noreferrer noopener">Palantir surging 24%.</a> Fed officials warned of inflation risks from tariffs, while job openings missed expectations.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/25/02/43485885/pharma-bro-martin-shkreli-defends-palantirs-valuation-amid-24-surge-says-ai-firms-cash-flow-justifies-expensive-price" rel="noreferrer noopener">&#8216;Pharma Bro&#8217; Martin Shkreli Defends Palantir&#8217;s Valuation Amid 24% Surge, Says AI Firm&#8217;s Cash Flow Justifies &#8216;Expensive&#8217; Price</a>.
In economic data, U.S. job openings fell by 556,000 to 7.6 million in December, missing estimates of 8.0 million. Factory orders dropped 0.9% to $578.5 billion, following a revised 0.8% decline in November.
Most S&amp;P 500 sectors ended higher, led by energy, tech, and communication services, while utilities and consumer staples declined.
The Dow Jones Industrial Average was up 0.30% and closed at 44,556.04, the S&amp;P 500 closed higher by 0.72% at 6,037.88, and the Nasdaq Composite rose 1.35% to finish at 19,654.02.
Aisa Markets Today
<ul>
<li>On Wednesday, Japan&#8217;s Nikkei 225 closed higher by 0.08% at 38,809.00, led by gains in the Textile, Marine Transport, and Services sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 gained 0.51% at 8,416.90, led by gains in the Gold, Metals &amp; Mining and Resources sectors.</li>
<li>India's Nifty 50 closed lower by 0.23% at 23,685.10, while Nifty 500 rose 0.22% closing at 21,776.00,</li>
<li>China&#8217;s Shanghai Composite fell 0.63% and closed at 3,229.49; Shanghai Shenzhen CSI 300 was down 0.56% at 3,795.08.</li>
<li>Hong Kong&#8217;s Hang Seng closed the session lower by 0.93% at 20,597.09.</li>
<li>Chinese markets fell as U.S.-China trade tensions escalated, with Shanghai and Hong Kong indexes declining. China announced retaliatory tariffs on U.S. goods, effective February 10, 2025.</li>
</ul>
Eurozone at 05:30 AM ET
<ul>
<li>The European STOXX 50 was down 0.22%.</li>
<li>Germany&#8217;s DAX fell 0.24%.</li>
<li>France&#8217;s CAC declined 0.25%.</li>
<li>U.K.&#8217;s FTSE index 100 traded lower by 0.01%.</li>
</ul>
Commodities at 05:30 AM ET
<ul>
<li>Crude Oil WTI was trading lower by 0.85% at $72.05/bbl, and Brent was down 0.88% at $75.53/bbl.</li>
<li>Oil prices declined as rising U.S. stockpiles and escalating trade tensions with China fueled economic growth concerns, countering Trump&#8217;s efforts to restrict Iranian crude exports.</li>
<li>Natural Gas declined 1.35% to $3.210.</li>
<li>Gold was trading higher by 0.55% at $2,891.46, Silver was down 0.16% to $32.965, and Copper rose 0.32% to $4.3680.</li>
</ul>
U.S. Futures at 05:30 AM ET
Dow futures were down 0.20%, S&amp;P 500 futures declined 0.56% and Nasdaq 100 futures slid 0.95%.
Forex at 05:30 AM ET
<ul>
<li>The U.S. dollar index declined 0.54% to 107.42, the USD/JPY fell 1.11% to 152.64, and the USD/AUD fell 0.49% to 1.5907.</li>
<li>The yuan weakened as U.S.-China trade tensions hit markets, while the yen surged on expectations of Bank of Japan rate hikes. The dollar fell against major currencies, with traders watching China&#8217;s response to tariffs and potential U.S. negotiations. Japan&#8217;s strong wage data fueled further yen gains.</li>
</ul>
Photo by Pavel Bobrovskiy via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Comments

C&C Group

News

Latest news for C&C Group (OTC:CCGPY) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga